ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Performance of Aged Liver Grafts in a Rat Model of Normothermic Ex Vivo Liver Machine Perfusion

    S. Moosburner1, M. Zimmer1, J. M. Gassner1, N. Roschke1, N. Berndt2, J. Michelotto1, K. H. Hillebrandt1, J. Pratschke1, I. M. Sauer1, N. Raschzok1

    1Department of Surgery, Experimental Surgery, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 2Institute of Biochemistry, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

    *Purpose: We aimed to characterize the performance of old vs. young liver grafts in a standardized rat model of normothermic ex vivo liver machine perfusion…
  • 2022 American Transplant Congress

    Clinical Implications of Robotically Assisted Laparoscopic Donor Nephrectomy: A Single Center Experience

    A. Popovic1, S. Loerzel2, M. Hanlon2, S. Iskhagi2, B. Gallay3, E. Shaban3, J. Leggat3, R. H. Dvorai4, S. Narsipur5, R. Saidi2, R. Shahbazov2

    1College of Medicine, SUNY, Upstate Medical University, Syracuse, NY, 2Surgery, Division of Transplantation, SUNY, Upstate Medical University, Syracuse, NY, 3Medicine, SUNY, Upstate Medical University, Syracuse, NY, 4Pathology, SUNY, Upstate Medical University, Syracuse, NY, 5SUNY, Upstate Medical University, Syracuse, NY

    *Purpose: Robotic assisted live donor nephrectomies (RDN) continue to increase in prevalence over the last years. Prior studies demonstrated outcomes of robotic procedures are no…
  • 2022 American Transplant Congress

    Application of Metagenomicnext-Generation Sequencing in the Diagnosis and Treatment of Recurrent Urinary Tract Infections in Kidney Transplant Recipients

    W. Duan, X. Tian, X. Wu, G. Cao, T. Yan

    Henan Province People's Hospital, Zhengzhou, Henan Province, China

    *Purpose: Rapid and accurate pathogen diagnosis is the key to the treatment of recurrent urinary tract infections (RUTI) after kidney transplant. Metagenomic next-generation sequencing (mNGS)…
  • 2022 American Transplant Congress

    Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience

    N. Eleti, G. Agarwal, S. Ong, C. Kew, D. Anderson, C. Young

    University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Weight gain is common following organ transplantation, and there exists concern that in simultaneous pancreas-kidney (SPK) recipients, this may lead to poorer graft outcomes.*Methods:…
  • 2022 American Transplant Congress

    Post-Simultaneous Kidney and Pancreas Transplant Outcomes in Type 2 Diabetes Compared to Type 1 Diabetes

    L. Liriano1, Y. Al Azzi2, S. Kapoor2, S. Jain1, M. Ajaimy3, P. Loarte2, C. Pynadath4, J. Graham2, S. Stefan1, E. Akalin5

    1Montefiore Medical Center, Bronx, NY, 2Montefiore Medical Center, New York, NY, 3Montefiore-Einstein Transplant Center, Scarsdale, NY, 4Montefiore Medical Center, Scarsdale, NY, 5Albert Einstein College of Medicine, Montefiore Medical Ctr, Bronx, NY

    *Purpose: To evaluate and compare short term and long-term outcomes in simultaneous kidney and pancreas transplant (SPK) recipients with a history of type 2 diabetes…
  • 2022 American Transplant Congress

    Evolving Trends In The Management And Outcome Of Duodenal Complications After Pancreas Transplantation: A 20-year Single Institution Experience

    S. Ray1, C. Parmentier1, G. Sapisochin1, A. Yousuf1, I. McGilvray1, A. Norgate1, M. Cattral1, M. Selzner2, T. Reichman3

    1Multiorgan transplantation, Toronto general hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3University of Toronto/The University Health Network, Toronto, ON, Canada

    *Purpose: Duodenal leaks have been a sinister complication in any major gastro-intestinal operation. With an incidence ranging from 4-10%, these have been one of the…
  • 2022 American Transplant Congress

    Transitional-1 B Cell IL-10/TNFα Ratio Risk-Stratifies Renal Transplant Patients with Early Borderline Change

    A. Cherukuri, P. Randhawa, S. Hariharan, D. Rothstein

    Thomas E. Starzl Transplantation Institute, UPMC, Pittsburgh, PA

    *Purpose: Recent studies have shown that Banff borderline change (BLC) on allograft biopsies (Bx) is associated with decreased graft survival. However, many patients with BLC…
  • 2022 American Transplant Congress

    Outcome Predictors with Perioperative Kidney Transplant Midodrine Usage

    R. Watson1, S. Mullins2, S. Williams3, F. Fakhre4, K. Robichaux4, S. Mohammed4, M. Gosselin3, A. Kumar5, J. Buggs1, V. Bowers1

    1Transplant Surgery, Tampa General Hospital, Tampa, FL, 2Florida A &M University, Tallahassee, FL, 3University of Tampa, Tampa, FL, 4University of South Florida, Tampa, FL, 5Morsani College of Medicine, University of South Florida, Tampa, FL

    *Purpose: Midodrine is an alpha-1 agonist drug commonly used to aid hypotension in kidney transplant patients. Little is described regarding outcomes with midodrine in kidney…
  • 2022 American Transplant Congress

    Evaluation of Post-Transplant Angiotensin II Type 1 Receptor Antibodies, Donor-Derived Cell-Free DNA, and Rejection in Heart Transplant Recipients

    B. Agegnehu1, S. Sterling1, R. Winstead1, I. Tchoukina2

    1Pharmacy, VCU Health System, Richmond, VA, 2Advanced Heart Failure and Transplant Cardiology, VCU Health System, Richmond, VA

    *Purpose: There is limited evidence evaluating the relationship between angiotensin II type 1 receptor antibodies (AT1R-Abs), donor-derived cell-free DNA (dd-cfDNA), and rejection in heart transplant…
  • 2022 American Transplant Congress

    The Impact of Neutralizing Antibodies on Polyomavirus Infections in Mice

    D. R. Butcher, B. D. Thompson, H. K. Singh, V. Nickeleit

    Pathology and Laboratory Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC

    *Purpose: Definitive polyomavirus nephropathy (PyVN) affects kidney transplants and impacts allograft function and survival. Data suggest that neutralizing PyV strain specific antibodies can attenuate and…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences